Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 10/2011

01-10-2011 | Research Articles

Prevention of acute radiation enteritis: efficacy and tolerance of glutamine

Authors: Ismael Membrive Conejo, Ana Reig Castillejo, Nuria Rodríguez de Dios, Palmira Foro Arnalot, Javier Sanz Latiesas, Joan Lozano Galán, Martí Lacruz Bassols, Jaime Quera Jordana, Enric Fernández-Velilla Cepria, Manuel Algara López

Published in: Clinical and Translational Oncology | Issue 10/2011

Login to get access
Metadata
Title
Prevention of acute radiation enteritis: efficacy and tolerance of glutamine
Authors
Ismael Membrive Conejo
Ana Reig Castillejo
Nuria Rodríguez de Dios
Palmira Foro Arnalot
Javier Sanz Latiesas
Joan Lozano Galán
Martí Lacruz Bassols
Jaime Quera Jordana
Enric Fernández-Velilla Cepria
Manuel Algara López
Publication date
01-10-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 10/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0729-3

Other articles of this Issue 10/2011

Clinical and Translational Oncology 10/2011 Go to the issue

Educational Series / Green Series

Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer

Research Articles

Molecular changes consistent with increased proliferation and invasion are common in rectal cancer

Editorial

Or why translational research is vital for the future treatment of rectal cancer

Research Articles

Does gender matter in glioblastoma?

Educational Series / Blue Series

MET and VEGF: synergistic targets in castration-resistant prostate cancer

Research Articles

A safety and toxicity assessment of the administration of multiple intracerebral injections of irinotecan or doxorubicin drug-eluting beads
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits